Bick will succeed Nancy Cox, PhD, who has led Genetic Medicine since she came to VUMC in 2015. Genetic Medicine is one of 13 divisions in the Department of Medicine.

A real-world learning health system was established at VUMC a decade ago. Now, the National Human Genome Research Institute is awarding two five-year grants totaling $12 million to support VUMC’s participation in, and coordination of, a genomic-enabled learning health system (gLHS) network.

Aldrich uses population-based cohorts and biobanks to investigate lung cancer; her research informed guidelines for lung cancer screening.

The subject of his Discovery Lecture, which will begin at 4 p.m. Sept. 26 in 208 Light Hall, is the role of ribosomes in initiating the translation of DNA into RNA, a precursor step to transcribing the genetic code into proteins that do the work of the cell.

Making innovative use of observational data, researchers hope to gain new understanding of patient risk and identify existing drugs to lower risk.

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

Without treatment, younger patients may develop other serious cardiac disorders such as heart failure or life-threatening ventricular arrhythmias.